News and features

Articles

Article type

Showing 1 - 10 of 11

News & Analysis
Image

LMG Life Sciences Americas Awards: 2021 shortlists announced

27 July 2021 by LMG Life Sciences

In-person event will be held on Sept. 22 in New York

News & Analysis

2021 firm and attorney rankings for North America now live

29 September 2021 by Chris Adams

This year's results recognize the most recommended in Canada and US across practice areas

News & Analysis

LMG Life Sciences Americas Awards: 2021 winners revealed

23 September 2021 by Chris Adams

Honorees were announced during a Sept. 22 awards dinner in New York

News & Analysis

About the Euromoney events protocol to promote attendee safety

17 August 2021 by Chris Adams

Read about our Covid-19 measures as we return to in-person events

News & Analysis

2021 North America research deadline extended

27 May 2021 by LMG Life Sciences

Firms can now provide submissions up to June 10

News & Analysis

Beyond Biosimilarity: Draft Guidance for Demonstrating Biological Interchangeability

06 September 2017 by LMG Life Sciences

The primary focus of the Food and Drug Administrationtion, industry and counsel preparing for the advent of follow-on biologics in the United States has been the legal and regulatory framework ...

News & Analysis

Licensing tips from a patent litigator

06 September 2017 by LMG Life Sciences

Anyone drafting patent license agreements should follow several tips in order to avoid or better prepare for litigation later on, says Jessamyn Berniker of Williams & Connolly.

News & Analysis

To Modify or Not to Modify, That is the Question

06 September 2017 by LMG Life Sciences

In IPRs regarding the patents to pharmaceutical compounds, patentability often turns on the obviousness of taking a known compound and modifying it based on a known technique.

News & Analysis

CFAD Fails to Knock Out 4 Acorda Patents to Multiple Sclerosis Drug

29 August 2017 by LMG Life Sciences

A recent set of final written decisions in four IPRs against Acorda Therapeutics puts more marks in the loss column for Kyle Bass and the Coalition for Affordable Drugs.

News & Analysis

A Q&A with Dom Conde of Fitzpatrick, Cella, Harper & Scinto

10 November 2016 by LMG Life Sciences

Dom Conde discusses Fitzpatrick's Hatch-Waxman ANDA practice